Acinetobacter baumannii is a multi-resistant opportunistic nosocomial pathogen responsible for several outbreaks worldwide. It can cause several infections at various sites of the body. One of the main infections caused by this bacterium is ventilator-associated pneumonia in patients in intensive care units. Treating these infections is becoming difficult because of the high resistance to antimicrobial agents. This study compared the expression of the chromosomally encoded bla ADC gene in isolates having ISAba1, ISAba125 and no insertion upstream of the bla ADC gene in A. baumannii clinical isolates. It showed that the expression of bla ADC was six times greater when ISAba125 was present upstream of the gene in comparison with the constitutively expressed bla ADC gene with no insertion present upstream. The study indicated that ISAba125 has better promoters than ISAba1 and this is responsible for the overexpression of the bla ADC gene as they share considerable homology to the well-established Escherichia coli promoters. The "10 box of ISAba125 formed a fusion promoter with the "35 box of the bla ADC gene causing the bla ADC gene to be significantly overexpressed. The ability to upregulate the expression of bla ADC with the assistance of different insertion elements such as ISAba1 and ISAba125 has become an important factor in A. baumannii resistance to cephalosporins.
INTRODUCTIONThe predominant mechanism of b-lactam resistance in Gram-negative bacteria is the synthesis of b-lactamases (Philippon et al., 2002). Following the introduction of highly stable cephalosporins, the carbapenems and monobactams, resistance initially appeared in organisms such as Enterobacter cloacae, Citrobacter freundii, Serratia marcescens and Pseudomonas aeruginosa, where mutations in the chromosome lead to the overproduction of the AmpC blactamase. This confers resistance to oxyimino-and 7-alphamethoxy-cephalosporins and monobactams (Sanders, 1987). Class C b-lactamases produced by Gram-negative bacteria can hydrolyse many b-lactam antibiotics including the cephamycins and oxyimino-cephalosporins (Philippon et al., 2002;Sanders, 1987;Caroff et al., 2000). These enzymes can also hydrolyse monobactams, such as aztreonam, to a lesser extent (Bush et al., 1995;Mammeri & Nordmann, 2007). Acinetobacter baumannii is a Gramnegative, non-fermenting coccobacillus, which is associated with serious nosocomial infections (Cisneros & Rodríguez-Baño, 2002;Levin et al., 2003). Antimicrobial treatment of such infections is difficult due to their multidrug resistance profile (Corvec et al., 2003). The AmpC enzyme from multiresistant A. baumannii was first sequenced from a Spanish isolate (Bou & Martínez-Beltrán, 2000). This constitutively expressed AmpC enzyme shares low similarity with Enterobacteriaceae AmpC cephalosporinases (Corvec et al., 2003). High-level expression of AmpC b-lactamase is a mechanism of chromosomally mediated resistance to cephalosporins in A. baumannii (Bou & Martínez-Beltrán, 2000). Transposable elements are important motors...